Insights & Publications

Pharmaceuticals & Medical Products

article | McKinsey Quarterly

Japan: Lessons from a hyperaging society

March 2015—The country’s population, already the world’s oldest, is aging quickly. Companies in Europe, North America, and Asia can learn from its experience.more

Editor's choice

Capturing the new value segment_1536x1536_Thumbnail

Capturing the new ‘value’ segment in medical devices

January 2015—The growing demand for products that are “good enough” and competitively priced has pushed medical-product manufacturers to develop strategies to attract and retain this new segment of customers.more

Medical-device manufacturers_1536x1536_Thumbnail

How medical-device manufacturers can transform marketing and sales capabilities

January 2015—Device manufacturers experiencing declining growth or narrowing margins may need to reevaluate their commercial models.more


Rapid growth in biopharma: Challenges and opportunities

December 2014—Biopharmaceuticals could become the core of the pharmaceutical industry, but not without significant transformation in the laboratory and in strategy, technology, and operations.more


A digital prescription for pharma companies

November 2014—Pharmaceutical and medical-device companies have been slow to adopt digitization. Here are five reasons they should get moving. more


Value creation in medical device M&A

September 2014—Successful large, transformative deals are rare in medical devices. With further consolidation ahead, future acquirers need to reconsider their approach in the context of a programmatic M&A strategy.more

article | McKinsey Quarterly

Confronting change fatigue in the pharmaceutical industry

September 2014—A decade of restructuring and transformation efforts has taken a toll on organizational health.more


Developing a global digital strategy

October 2014—How does a global company take advantage of digital technology? Johnson & Johnson’s vice president of digital strategy, Gail Horwood, explains.more

  • includes:

Pharma’s first-to-market advantage

September 2014—What’s the value of bringing a drug to market first? In some cases, it may be less than you think.more


Healthcare’s digital future

July 2014—Insights from our international survey can help healthcare organizations plan their next moves in the journey toward full digitization.more


Designing for social impact: The D-Rev story

June 2014—Many companies target the world’s emerging middle-class consumers. Fewer mirror nonprofit D-Rev, which aims to improve the health and lives of people living on less than $4 a day.more

  • includes:

About this content

The material on this page draws on the research and experience of McKinsey consultants and other sources. To learn more about our expertise, please visit the Pharmaceuticals & Medical Products Practice.